Great distinction for Dr. Giannis Zacharakis, Principal Researcher of FORTH-IESLGreat distinction for Dr. Giannis Zacharakis, Principal Researcher at the Institute of Electronic Structure and Laser of FORTH, who took over responsibilities as President of the European Society for Molecular Imaging (ESMI.

New Paper by FORTH researchers published in Nature CommunicationsGraphene, as one-atom-thick membrane, is susceptible to morphological instabilities such as wrinkles, crumples and folds, which are attributed to several physical causes, such as the mismatch between its thermal expansion and its host substrate or the relaxation of a pre-strained substrate. A particular pattern encountered in graphene grown via Chemical Vapour Deposition is that of mosaic formation, which results from the imposition of thermo-mechanical stresses upon cooling from high temperatures.

Important Distinction for Prof. Dimitris Vlassopoulos, Affiliated Faculty Member of the Institute of Electronic Structure and Laser of FORTHDimitris Vlassopoulos, Professor of the Department of Materials Science and Technology of the Unversity of Crete and Affiliated Faculty Members of the Institute of Electronic Structure and Laser (IESL) of the Foundation for Research and Technology – Hellas (FORTH), has been elected to receive the Bingham Medal of the Society of Rheology of the USA for 2019

International scientific collaboration between IMBB Researchers and Scientists at the National Institutes of Health (NIH) of the United States and the University of Oslo, in Norway uncovers the novel role of mitophagy in the pathogenesis of Alzheimer’s disease.The findings of the study, published today in the premier international scientific journal Nature Neuroscience, reveal a novel molecular mechanism underlying the beneficial effects of mitophagy, the cellular process of mitochondria recycling, against the pathogenesis of Alzheimer’s disease. IMBB Researchers, Dr. Konstantinos Palikaras and Dr. Nektarios Tavernarakis (Professor at the Medical School, University of Crete, and Chairman of the Board at FORTH) in collaboration with the team of Prof. Vilhem Bohr at the National Institute on Aging (NIA) of the National Institutes of Health, (NIH) in Baltimore, USA, together with Dr. Evandro Fang at the University of Oslo and the Akershus University Hospital, Lørenskog, Norway, demonstrated that mitophagy is impaired inAlzheimer’s disease and that its pharmacological stimulation reverses the disease’s pathological features, including cognitive deficits.